A leading scientist battling to halt the development of Multiple Sclerosis has revealed that clinical human trials will start by 2020, after her company was honoured with a major nano medicine award. Dr Su Metcalfe’s regenerative nanomedicine company, LIFNano™, was named Most Promising Nanomedicine Project at the International Nano Medicine Awards in Berlin on Tuesday, November 7…..
https://nano-magazine.com/news/2017/11/7/uk-company-wins-global-medicine-award-for-its-ground-breaking-potential-ms-treatment/?email=ramjitti@nanotec.or.th
